loading...

Contact| FAQ
Submit a request

Disability Assessment for Dementia (DAD)

Gauthier L; Gelinas I

Distributed by Mapi Research Trust

ProQolid

Distributed by Mapi Research Trust

Basic description

WEBINAR: An Author Webinar on the Disability Assessment for Dementia -Recorded session available here!

Please have a look at this press release

Authors

Gauthier L; Gelinas I

Copyright
DAD © 1994 by L. Gauthier & I. Gélinas
Objective
To quantitatively measure functional abilities in activities of daily living (ADL) in individuals with cognitive impairments such as dementia
Therapeutic area
  • Nervous System Diseases
  • Mental Disorders
Therapeutic indication
  • Alzheimer Disease
  • Dementia
Type of Clinical Outcome Assessment (COA)
  • obsro ObsRO
Original language(s)
  • English for Canada
  • French for Canada
DAD developed simultaneously in English & French for Canada
Bibliographic reference(s) of the original questionnaire

Gélinas I, Gauthier L, McIntyre M, Gauthier S. Development of a functional measure for persons with Alzheimer's disease: the disability assessment for dementia. Am J Occup Ther. 1999 Sep-Oct;53(5):471-81 (Full Text Article)

Gauthier S, Gelinas I, Gauthier L. Functional disability in Alzheimer's disease. Int Psychogeriatr. 1997;9 Suppl 1:163-5 (PubMed Abstract)

Contact and conditions of use

Authors

Gauthier L; Gelinas I

Isabelle Gélinas, PhD, OT(c), erg
Associate Professor
School of Physical & Occupational Therapy
McGill University
3654 Promenade Sir William Osler (Drummond)
Montreal, Quebec, H3G 1Y5- Canada
E-mail: isabelle.gelinas@mcgill.ca

Contact information

Mapi Research Trust
PROVIDE™
27 rue de la Villette
69003 Lyon
France
Phone: +33 (0)4 72 13 66 66

Conditions of use

Non-Commercial Users

If you do not receive specific funding for your study, you may download the questionnaire directly:

  1. Log in or Register for free
  2. Click the 'Online distribution' tab in the left menu bar and follow the instructions

Tutorials are available on our FAQs.

Commercial Users

All requests have to be submitted through our online request management:

  1. Log in or Register for free
  2. Submit your request (Tutorials are available on our FAQs)
  3. In order to accelerate the process, you may attach the User Agreement (even if not finalized) to your online request. Click the link below for the user agreement template.
  4. Our PROVIDE team will get back to you with the needed information in a timely manner

Access fees

ROYALTY FEES* Commercial users Cost per study 1 100 €
Cost per language 550 €
Funded academic research Cost per study Free
Cost per language Free
Not funded academic users Cost per study Free
Cost per language Free
DISTRIBUTION FEES* Commercial users Cost per study 1 000 €
Cost per language 500 €
Funded academic research Cost per study 300 €
Cost per language 50 €
Not funded academic users Cost per study Free
Cost per language Free

* Excluding VAT
Commercial users: Industry, CRO, any for-profit companies
Funded Academic research: Projects receiving funding from commerce, government, EU or registered charity. Funded academic research– sponsored by industry fits the “commercial users” category.
Not funded academic users, individual medical practice: Projects are not explicitly funded, but funding comes from overall departmental funds or from the University or individual funds

Conditions to translate

Please refer to the "Languages" tab

Conditions to implement in electronic applications

Exclusive licensor for e-versions of the questionnaire: Mapi Research Trust

Academic and Commercial Users
  • Shall follow the “Conditions of use”  mentioned above
  • In addition, in case the electronic version of the questionnaire is developed by a third party (IT Company, e-PRO vendor…), User shall check with Mapi Research Trust that this third party has signed the necessary License Agreement with Mapi Research Trust before developing the electronic version of the Questionnaire.

Information Technology (IT) Companies (incl. ePRO vendors)
  • In case of a one-shot development and commercial use of an electronic version of the questionnaire by the IT Company, the IT Company shall:
    • Sign a “Specific-Study License Agreement with IT Company” with Mapi Research Trust
      • authorizing the electronic implementation of the questionnaire for the specific study only
      • shall not permit the IT Company to promote the electronic version of the questionnaire or its use for another study or another client
    • Pay a one-shot license fee per study to Mapi Research Trust: 500 Euros
  • In case of an IT Company who wishes to develop an electronic version of the questionnaire and would like to obtain a non-exclusive license to market and promote their devices / tablets / smartphones / e-applications using the questionnaire, the IT Company shall:
    • Sign a “General License Agreement with IT Company” with Mapi Research Trust
      • authorizing the electronic implementation of the questionnaire on multiple devices for multiple studies and clients
      • permitting the IT Company to promote the electronic versions of the questionnaire by any marketing means (including, but not limited to, IT Company’s  promotional documents / websites / press release / communication during conferences / webinars)
    • Pay an annual administrative fee of 2,500 Euros to Mapi Research Trust
    • Pay an annual royalty fee of 2,500 Euros to the author(s)

Review copy

Examination copies can only be used for the limited purpose of examining the suitability of the Questionnaire for subsequent research and/or clinical use, and cannot be used in research or in clinical practice or distributed to others.
You are not authorized to modify, retype, translate, copy or otherwise duplicate the Questionnaire except with the further and prior written permission of Mapi Research Trust / the developers / copyright holders / distributors.

Languages

Original language(s)

  • English for Canada
  • French for Canada
DAD developed simultaneously in English & French for Canada

Translations

The listed translations may not have undergone a full linguistic validation process and may require further work to be suitable for use in a study. This list is subject to constant changes, therefore please check the status of translations with Mapi Research Trust / the developers / copyright holders / distributors.

DAD

Afrikaans for South Africa*
Bulgarian for Bulgaria*
Cantonese for Hong Kong
Croatian for Croatia*
Czech for Czech Republic*
Danish for Denmark*
Dutch for Belgium (Flemish)*
Dutch for the Netherlands*
English for Australia*
English for Hong Kong*
English for Israel*
English for Malaysia*
English for New Zealand*
English for Singapore*
English for South Africa*
English for the Philippines*
English for the UK*
English for the USA*
Estonian for Estonia*
Finnish for Finland*
French for Belgium*
French for France*
German for Austria*
German for Germany*
German for Switzerland*
Greek for Greece*
Hebrew for Israel*
Hindi for India*
Hungarian for Hungary*
Italian for Italy*
Kannada for India*
Korean for Korea*
Malay*
Malayalam for India*
Mandarin for China*
Mandarin for Malaysia*
Mandarin for Singapore*
Mandarin for Taiwan*
Marathi for India*
Polish for Poland*
Portuguese for Brazil*
Portuguese for Portugal*
Romanian for Romania*
Russian for Estonia*
Russian for Israel*
Russian for Russia*
Russian for Ukraine*
Slovak for Slovakia*
Slovenian for Slovenia*
Spanish for Argentina*
Spanish for Chile*
Spanish for Mexico*
Spanish for Peru*
Spanish for Spain*
Spanish for the USA*
Swedish for Sweden*
Tagalog for the Philippines*
Tamil for India*
Turkish for Turkey*
Ukrainian for Ukraine*
Urdu for Pakistan*
* Performed by Mapi

The author has selected Mapi as exclusive linguistic validation company to ensure the production of harmonized and consistent language versions.

For additional information on available translations of this instrument, or for a project involving new languages, please submit a request (tutorials available on our FAQs).

Conditions to translate

Commercial Users

Exclusive vendor for translation work for commercial users: Mapi

Academic Translation

If you wish to translate the questionnaire:

  1. Log in or Register for free
  2. Submit your request for translation online (Tutorials are available on our FAQs)
  3. Our PROVIDE team will send you a translation agreement along with Linguistic Validation Guidelines.

More information on translations

For information on, or permission to use the translation(s), please contact: Mapi Research Trust

Online distribution

My study is not funded

  • I am a non-commercial user
  • I do not receive specific funding for my study
  • I intend to use the questionnaire in individual clinical practice or research study
Login SIGN up free

My study is funded

If your study is funded, or if you haven't found your translation in the Languages menu, please submit your request online.

Our team will get back to you as soon as possible.

Submit a Request

Member Access

Subscribe to PROQOLID to access to full informations

And get access to advanced descriptions of Clinical Outcome Assessments (COAs)!

MORE INFORMATION Subscribe NOW
A question? Contact us